OBJECTIVES: In 2005, England and Wales switched from universal BCG vaccination against tuberculosis (TB) disease for school-age children to targeted vaccination of neonates. We aimed to recreate and re-evaluate a previously published model, the results of which informed this policy change. DESIGN: We recreated an approach for estimating the impact of ending the BCG schools scheme, correcting a methodological flaw in the model, updating the model with parameter uncertainty and improving parameter estimates where possible. We investigated scenarios for the assumed annual decrease in TB incidence rates considered by the UK's Joint Committee on Vaccination and Immunisation and explored alternative scenarios using notification data. SETTING: Eng...
BACKGROUND: In July 2008 a case of smear-positive pulmonary tuberculosis (TB) in a white UK-born nur...
National policies regarding the BCG vaccine for tuberculosis vary greatly throughout the internation...
The impact of COVID-19 disruptions on global Bacillus Calmette-Guérin (BCG) coverage and paediatric ...
BackgroundIn 2005 in England, universal Bacillus Calmette-Guérin (BCG) vaccination of school-age chi...
Background: Until recently, evidence that protection from the bacillus Calmette–Guérin (BCG) vaccina...
BACKGROUND: Until recently, evidence that protection from the bacillus Calmette-Guérin (BCG) vaccina...
In 2005, England and Wales switched from universal BCG vaccination against tuberculosis (TB) disease...
BACKGROUND: Until recently, evidence that protection from the bacillus Calmette-Guérin (BCG) vaccina...
BACKGROUND: BCG has been recommended at birth in countries with a high tuberculosis burden for decad...
Background Bacillus Calmette-Guérin (BCG) vaccination is a widely-used public health intervention fo...
Background Until recently, evidence that protection from the bacillus Calmette–Guérin (BCG) vaccina...
The decrease in overall incidence of TB in industrialised countries, together with the increasing co...
Until recently, evidence that protection from the bacillus Calmette-Guérin (BCG) vaccination lasted ...
BCG uptake among infants in England has not been measured since targeted infant vaccination replaced...
BACKGROUND: Evidence of protection from childhood Bacillus Calmette-Guerin (BCG) against tuberculosi...
BACKGROUND: In July 2008 a case of smear-positive pulmonary tuberculosis (TB) in a white UK-born nur...
National policies regarding the BCG vaccine for tuberculosis vary greatly throughout the internation...
The impact of COVID-19 disruptions on global Bacillus Calmette-Guérin (BCG) coverage and paediatric ...
BackgroundIn 2005 in England, universal Bacillus Calmette-Guérin (BCG) vaccination of school-age chi...
Background: Until recently, evidence that protection from the bacillus Calmette–Guérin (BCG) vaccina...
BACKGROUND: Until recently, evidence that protection from the bacillus Calmette-Guérin (BCG) vaccina...
In 2005, England and Wales switched from universal BCG vaccination against tuberculosis (TB) disease...
BACKGROUND: Until recently, evidence that protection from the bacillus Calmette-Guérin (BCG) vaccina...
BACKGROUND: BCG has been recommended at birth in countries with a high tuberculosis burden for decad...
Background Bacillus Calmette-Guérin (BCG) vaccination is a widely-used public health intervention fo...
Background Until recently, evidence that protection from the bacillus Calmette–Guérin (BCG) vaccina...
The decrease in overall incidence of TB in industrialised countries, together with the increasing co...
Until recently, evidence that protection from the bacillus Calmette-Guérin (BCG) vaccination lasted ...
BCG uptake among infants in England has not been measured since targeted infant vaccination replaced...
BACKGROUND: Evidence of protection from childhood Bacillus Calmette-Guerin (BCG) against tuberculosi...
BACKGROUND: In July 2008 a case of smear-positive pulmonary tuberculosis (TB) in a white UK-born nur...
National policies regarding the BCG vaccine for tuberculosis vary greatly throughout the internation...
The impact of COVID-19 disruptions on global Bacillus Calmette-Guérin (BCG) coverage and paediatric ...